These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34420368)

  • 1. Cardiovascular Benefits of Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Black Hypertensive Patients.
    Brook RD; Kaciroti N; Jamerson T; Jamerson KA
    Hypertension; 2021 Sep; 78(4):1150-1152. PubMed ID: 34420368
    [No Abstract]   [Full Text] [Related]  

  • 2. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
    Brook RD; Kaciroti N; Bakris G; Dahlöf B; Pitt B; Velazquez E; Weber M; Zappe DH; Hau T; Jamerson KA
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.
    Chrysant SG
    Drugs R D; 2012 Jun; 12(2):57-64. PubMed ID: 22571394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of combination treatment for hypertension in black Africans.
    Onakpoya I
    BMJ Evid Based Med; 2020 Jun; 25(3):112. PubMed ID: 31619455
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
    Bakris G; Hester A; Weber M; Dahlof B; Pitt B; Velasquez E; Staikos-Byrne L; Shi V; Jamerson K;
    J Cardiometab Syndr; 2008; 3(4):229-33. PubMed ID: 19040592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
    Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M
    Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
    Winer N; Folker A; Murphy JA; Hung E; Bard M; Perkelvald A; Sowers JR; Bakris GL
    Prev Cardiol; 2005; 8(2):87-92. PubMed ID: 15860983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
    Jamerson K; Weber MA; Bakris GL; Dahlöf B; Pitt B; Shi V; Hester A; Gupte J; Gatlin M; Velazquez EJ;
    N Engl J Med; 2008 Dec; 359(23):2417-28. PubMed ID: 19052124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
    Weir MR; Ferdinand KC; Flack JM; Jamerson KA; Daley W; Zelenkofske S
    Hypertension; 2005 Sep; 46(3):508-13. PubMed ID: 16116046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes.
    Shigihara T; Sato A; Hayashi K; Saruta T
    Hypertens Res; 2000 May; 23(3):219-26. PubMed ID: 10821130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Davis BR; Whelton PK;
    N Engl J Med; 2009 Mar; 360(11):1148-9; author reply 1149-50. PubMed ID: 19283889
    [No Abstract]   [Full Text] [Related]  

  • 14. Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials.
    Lv Y; Zou Z; Chen GM; Jia HX; Zhong J; Fang WW
    Blood Press Monit; 2010 Aug; 15(4):195-204. PubMed ID: 20512032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker.
    Bakris GL
    J Clin Hypertens (Greenwich); 2008 Jan; 10(1 Suppl 1):27-32. PubMed ID: 18174781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Osswald H; Mühlbauer B
    J Hypertens Suppl; 1995 Aug; 13(2):S21-8. PubMed ID: 8576784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The study of effects of ramipril and amlodipine combination in patients with arterial hypertension and type 2 diabetes mellitus].
    Tkacheva ON; Barabashkina AV; Novikova IM; Runikhina NK
    Kardiologiia; 2009; 49(5):40-7. PubMed ID: 19463134
    [No Abstract]   [Full Text] [Related]  

  • 19. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M
    Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.